SEC Form D private-offering filing

Senti Biosciences Holdings, Inc.

Name: Senti Biosciences Holdings, Inc. - new SEC Form D private-offering filing, South San Francisco, CA
Published: 2026-06-04

A new SEC Form D private-offering notice from South San Francisco, CA, a $40,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Senti Biosciences Holdings, Inc. site↗ Verified via SEC Form D

Clinical stage synthetic biology company developing gene circuit engineered cell and gene therapies for cancer, including SENTI-202 for acute myeloid leukemia.

Filed 2026-06-04Filed to raise $40,000,000First money in 2026-05-20Raised so far $10,000,000HQ (as filed) South San Francisco, CASector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified sentibio.com↗Named in the filing 10 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.